The Supreme Court on Thursday rejected a challenge to the abortion pill in a setback for the pro-life movement.

In a unanimous 9-0 ruling, the justices rejected a lawsuit from a group of doctors opposed to abortion who were pushing for more restrictions on mifepristone, one of two drugs frequently taken together to cause an abortion.

The ruling means mifepristone pills can continue to be mailed to patients without seeing a doctor in person.

In the opinion of the court, Justice Brett Kavanaugh wrote that the doctors who brought the case lacked standing to challenge the Food and Drug Administration’s (FDA) previous approval of the abortion pill.

CLICK HERE TO GET THE DAILYWIRE+ APP

“Those standing allegations suffer from the same problem—a lack of causation. The causal link between FDA’s regulatory actions and those alleged injuries is too speculative or otherwise too attenuated to establish standing,” Kavanaugh wrote.

The case, FDA v. Alliance for Hippocratic Medicine, was the first major abortion case to come before the Supreme Court since 2022 when it overturned Roe v. Wade, the landmark case that legalized abortion nationwide.

“We recognize that many citizens, including the plaintiff doctors here, have sincere concerns about and objections to others using mifepristone and obtaining abortions,” Kavanaugh wrote. “But citizens and doctors do not have standing to sue simply because others are allowed to engage in certain activities – at least without the plaintiffs demonstrating how they would be injured by the government’s alleged under-regulation of others.”